June 14, 2021
Reston, VA—Helen Nadel, MD, FRCPC, director of pediatric nuclear medicine at Lucile Packard Children’s Hospital at Stanford and clinical professor of radiology at the Stanford School of Medicine in Stanford, California, has been named as vice president-elect for the Society of Nuclear Medicine and Molecular Imaging (SNMMI). SNMMI introduced a new slate of officers during its 2021 Virtual Annual Meeting, held June 11-15.
Reflecting upon recent experiences with the COVID-19 pandemic, Nadel has set goals to ensure the field of nuclear medicine and molecular imaging will be well-prepared for the future. “The pandemic highlighted many ways in which we can improve our field, from radiopharmaceutical supply to government cooperation to safety and equity for our scientists, technologists, nurses, physicians, and patients,” she said.
To accomplish these goals, Nadel proposes creating an ongoing working group to address preparedness issues, educating members on potential risks, and developing rapid global communication and mobilization plans. She encourages SNMMI’s continued cooperation with government and industry to develop and quickly approve diagnostic and theranostic molecular agents, as well as associated hardware. Nadel also strongly supports SNMMI’s diversity initiatives to ensure an inclusive working environment and deliver quality health care to all patients regardless of gender or ethnicity.
Nadel earned her medical degree from the University of Manitoba in Winnipeg, Manitoba, Canada, in 1977. She completed a diagnostic radiology residency in 1982 at the University of Toronto, followed by a fellowship in pediatric radiology at the Hospital for Sick Children at the University of Toronto, both in Toronto, Ontario, Canada. She then completed a nuclear medicine residency in 1989 at the University of British Columbia, in Vancouver, British Columbia, Canada. Nadel held multiple academic appointments at the University of British Columbia between 1983 and 2018 and was head of the division of nuclear medicine and department of radiology at British Columbia Children’s Hospital before taking on her current roles at Stanford.
Nadel has been an active SNMMI member for more than 30 years, serving as a member of the House of Delegates and on the Pediatric Imaging Council board, PET Center of Excellence board of directors, Scientific Program Committee, Membership Committee and The Journal of Nuclear Medicine editorial board, among other posts. She was president of the SNMMI Pacific Northwest Chapter for many years and currently plays an active role in the Northern California chapter.
In the greater nuclear medicine community, Nadel has served in multiple positions for the American College of Nuclear Medicine, the American Board of Nuclear Medicine, the Radiological Society of North America, and the Children’s Oncology Group. In 2019, Nadel received the Lifetime Achievement Award from the European Society of Pediatric Nuclear Medicine for ongoing contributions to pediatric nuclear medicine. She has published 66 peer-reviewed journal articles, one book and 23 book chapters, and has been an invited speaker for 180 presentations.
Other SNMMI officers elected for 2021-22 are Richard L. Wahl, MD, St, Louis, Missouri, as president and Munir Ghesani, MD, FACNM, FACR, New York, New York, as president-elect. SNMMI Technologist Section officers for 2021-22 are Dusty York, MAEd, CNMT, PET, ARRT(N)(CT), Chattanooga, TN, as president and Krystle W. Glasgow, MIS, CNMT, NMTCB(CT), NMAA, FSNMMI-TS, Birmingham, Alabama, as president-elect.
# # #
About the Society of Nuclear Medicine and Molecular Imaging
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is an international scientific and medical organization dedicated to advancing nuclear medicine and molecular imaging—vital elements of precision medicine that allow diagnosis and treatment to be tailored to individual patients in order to achieve the best possible outcomes.
SNMMI’s members set the standard for molecular imaging and nuclear medicine practice by creating guidelines, sharing information through journals and meetings and leading advocacy on key issues that affect molecular imaging and therapy research and practice. For more information, visit www.snmmi.org.